| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Aneurysm, Abdominal | 29 | 2015 | 139 | 2.190 |
Why?
|
| Vascular Surgical Procedures | 19 | 2017 | 168 | 1.830 |
Why?
|
| Ischemia | 21 | 2017 | 229 | 1.480 |
Why?
|
| Blood Vessel Prosthesis | 32 | 2000 | 182 | 1.350 |
Why?
|
| Peripheral Arterial Disease | 7 | 2018 | 83 | 1.240 |
Why?
|
| Lower Extremity | 5 | 2017 | 153 | 0.920 |
Why?
|
| Popliteal Artery | 9 | 2015 | 40 | 0.810 |
Why?
|
| Leg | 19 | 2011 | 191 | 0.800 |
Why?
|
| Aortic Rupture | 11 | 2003 | 32 | 0.780 |
Why?
|
| Endovascular Procedures | 4 | 2017 | 366 | 0.700 |
Why?
|
| Postoperative Complications | 32 | 2017 | 1615 | 0.640 |
Why?
|
| Blood Vessel Prosthesis Implantation | 10 | 2018 | 186 | 0.630 |
Why?
|
| Quality Indicators, Health Care | 5 | 2017 | 136 | 0.610 |
Why?
|
| Aorta, Abdominal | 22 | 2000 | 97 | 0.610 |
Why?
|
| Decision Support Techniques | 2 | 2015 | 191 | 0.570 |
Why?
|
| Aortic Aneurysm | 13 | 1992 | 77 | 0.560 |
Why?
|
| Aged, 80 and over | 46 | 2016 | 4848 | 0.560 |
Why?
|
| Intermittent Claudication | 9 | 2018 | 31 | 0.560 |
Why?
|
| Aged | 84 | 2018 | 14862 | 0.550 |
Why?
|
| Carotid Stenosis | 4 | 2005 | 163 | 0.540 |
Why?
|
| Aorta | 10 | 2000 | 316 | 0.520 |
Why?
|
| Arterial Occlusive Diseases | 13 | 1997 | 134 | 0.480 |
Why?
|
| Aortic Diseases | 8 | 2000 | 113 | 0.470 |
Why?
|
| Middle Aged | 73 | 2018 | 21147 | 0.410 |
Why?
|
| Iliac Artery | 9 | 1999 | 44 | 0.410 |
Why?
|
| Aneurysm | 9 | 2002 | 53 | 0.400 |
Why?
|
| Prosthesis-Related Infections | 5 | 1999 | 70 | 0.400 |
Why?
|
| Male | 101 | 2018 | 37321 | 0.400 |
Why?
|
| Humans | 132 | 2018 | 68618 | 0.390 |
Why?
|
| Vascular Diseases | 6 | 1998 | 94 | 0.390 |
Why?
|
| Quality Improvement | 4 | 2017 | 413 | 0.380 |
Why?
|
| Female | 98 | 2018 | 38074 | 0.380 |
Why?
|
| Retrospective Studies | 40 | 2018 | 7277 | 0.380 |
Why?
|
| Risk Factors | 36 | 2018 | 5731 | 0.360 |
Why?
|
| Thrombosis | 10 | 2002 | 218 | 0.360 |
Why?
|
| Hypertension, Renovascular | 7 | 1995 | 47 | 0.360 |
Why?
|
| Fistula | 4 | 1997 | 29 | 0.350 |
Why?
|
| Kidney Failure, Chronic | 4 | 1997 | 365 | 0.350 |
Why?
|
| Endarterectomy, Carotid | 4 | 2001 | 110 | 0.350 |
Why?
|
| Treatment Outcome | 34 | 2018 | 7029 | 0.350 |
Why?
|
| Femoral Artery | 12 | 1999 | 139 | 0.340 |
Why?
|
| Intestinal Fistula | 4 | 1999 | 26 | 0.330 |
Why?
|
| Aortic Aneurysm, Thoracic | 6 | 2004 | 134 | 0.330 |
Why?
|
| Renal Artery | 8 | 1995 | 29 | 0.330 |
Why?
|
| Time Factors | 29 | 2018 | 4655 | 0.330 |
Why?
|
| Vena Cava, Inferior | 4 | 2000 | 41 | 0.320 |
Why?
|
| Graft Occlusion, Vascular | 8 | 1999 | 73 | 0.320 |
Why?
|
| Chi-Square Distribution | 7 | 2018 | 546 | 0.310 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2017 | 504 | 0.290 |
Why?
|
| Registries | 8 | 2018 | 733 | 0.290 |
Why?
|
| Vascular Grafting | 2 | 2017 | 12 | 0.280 |
Why?
|
| Survival Rate | 18 | 2002 | 1056 | 0.270 |
Why?
|
| Follow-Up Studies | 28 | 2011 | 3259 | 0.270 |
Why?
|
| Ultrasonography, Doppler, Duplex | 3 | 2005 | 25 | 0.260 |
Why?
|
| Carotid Artery, Internal | 2 | 2005 | 85 | 0.260 |
Why?
|
| Logistic Models | 7 | 2018 | 1420 | 0.250 |
Why?
|
| Arteriosclerosis | 7 | 1997 | 137 | 0.240 |
Why?
|
| Endarterectomy | 11 | 1995 | 22 | 0.240 |
Why?
|
| Disease-Free Survival | 5 | 2017 | 349 | 0.230 |
Why?
|
| Catheterization | 3 | 1997 | 209 | 0.230 |
Why?
|
| Coronary Disease | 9 | 2002 | 358 | 0.230 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 212 | 0.220 |
Why?
|
| Healthcare Disparities | 2 | 2017 | 378 | 0.210 |
Why?
|
| Patient Selection | 6 | 2016 | 592 | 0.210 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2015 | 373 | 0.210 |
Why?
|
| Carotid Artery Diseases | 7 | 1994 | 83 | 0.210 |
Why?
|
| Aortitis | 2 | 1997 | 5 | 0.210 |
Why?
|
| Limb Salvage | 3 | 2018 | 39 | 0.200 |
Why?
|
| United States | 11 | 2018 | 7367 | 0.200 |
Why?
|
| Adult | 45 | 2011 | 21403 | 0.200 |
Why?
|
| Reoperation | 13 | 2015 | 467 | 0.190 |
Why?
|
| Specialties, Surgical | 1 | 2001 | 19 | 0.190 |
Why?
|
| Benchmarking | 3 | 2016 | 91 | 0.190 |
Why?
|
| Splenic Artery | 2 | 2002 | 16 | 0.190 |
Why?
|
| Embolism, Cholesterol | 1 | 2000 | 3 | 0.180 |
Why?
|
| Aneurysm, Ruptured | 5 | 2004 | 40 | 0.180 |
Why?
|
| Head and Neck Neoplasms | 1 | 2005 | 561 | 0.170 |
Why?
|
| Odds Ratio | 4 | 2017 | 880 | 0.170 |
Why?
|
| Incidence | 10 | 2005 | 1603 | 0.170 |
Why?
|
| Minnesota | 8 | 2004 | 27 | 0.170 |
Why?
|
| Iliac Vein | 2 | 1998 | 10 | 0.170 |
Why?
|
| Hospitals, Group Practice | 1 | 1998 | 2 | 0.160 |
Why?
|
| Blood Transfusion, Autologous | 2 | 1989 | 17 | 0.160 |
Why?
|
| Cerebrovascular Disorders | 7 | 2001 | 182 | 0.160 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 1465 | 0.160 |
Why?
|
| Managed Care Programs | 1 | 1998 | 45 | 0.160 |
Why?
|
| Arteriovenous Fistula | 1 | 1998 | 25 | 0.160 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1998 | 69 | 0.150 |
Why?
|
| Ultrasonography | 10 | 2000 | 453 | 0.150 |
Why?
|
| Renal Circulation | 2 | 1998 | 49 | 0.150 |
Why?
|
| Elective Surgical Procedures | 5 | 2015 | 95 | 0.150 |
Why?
|
| Polytetrafluoroethylene | 4 | 1998 | 55 | 0.150 |
Why?
|
| Radiography | 9 | 2000 | 572 | 0.150 |
Why?
|
| Comorbidity | 3 | 2018 | 1426 | 0.150 |
Why?
|
| Linear Models | 2 | 2017 | 521 | 0.150 |
Why?
|
| Renal Artery Obstruction | 6 | 2002 | 29 | 0.140 |
Why?
|
| Myocardial Infarction | 4 | 2015 | 807 | 0.140 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 1999 | 130 | 0.140 |
Why?
|
| Carotid Arteries | 4 | 1991 | 110 | 0.140 |
Why?
|
| Blood Transfusion | 2 | 1989 | 205 | 0.140 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 1996 | 21 | 0.140 |
Why?
|
| Regional Medical Programs | 1 | 2016 | 22 | 0.140 |
Why?
|
| Monitoring, Intraoperative | 1 | 1996 | 53 | 0.140 |
Why?
|
| Uremia | 2 | 1995 | 10 | 0.140 |
Why?
|
| Proportional Hazards Models | 6 | 2018 | 792 | 0.140 |
Why?
|
| Superior Vena Cava Syndrome | 3 | 1998 | 15 | 0.130 |
Why?
|
| Smoking | 5 | 2018 | 1452 | 0.130 |
Why?
|
| Vena Cava, Superior | 2 | 1998 | 41 | 0.130 |
Why?
|
| Risk Assessment | 3 | 2015 | 2007 | 0.120 |
Why?
|
| Angiography | 9 | 2002 | 194 | 0.120 |
Why?
|
| Risk | 8 | 2000 | 563 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2015 | 100 | 0.120 |
Why?
|
| Saphenous Vein | 5 | 1998 | 61 | 0.110 |
Why?
|
| Mesenteric Vascular Occlusion | 4 | 2002 | 20 | 0.110 |
Why?
|
| Intestines | 2 | 1993 | 114 | 0.110 |
Why?
|
| Regional Health Planning | 1 | 2013 | 7 | 0.110 |
Why?
|
| Prognosis | 9 | 1998 | 2093 | 0.110 |
Why?
|
| Sigmoid Diseases | 1 | 1993 | 8 | 0.110 |
Why?
|
| Age Factors | 6 | 2002 | 1864 | 0.110 |
Why?
|
| Nephrectomy | 3 | 1995 | 103 | 0.110 |
Why?
|
| Mesentery | 3 | 2002 | 17 | 0.110 |
Why?
|
| Intracranial Arteriosclerosis | 1 | 1994 | 134 | 0.100 |
Why?
|
| Cohort Studies | 6 | 2011 | 2358 | 0.100 |
Why?
|
| Carotid Body Tumor | 2 | 1988 | 4 | 0.100 |
Why?
|
| Case-Control Studies | 6 | 2011 | 1553 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 58 | 0.100 |
Why?
|
| Neuralgia | 2 | 1993 | 27 | 0.090 |
Why?
|
| Fibrinolytic Agents | 2 | 1985 | 377 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 1 | 2011 | 149 | 0.090 |
Why?
|
| Blood Pressure | 6 | 1998 | 1451 | 0.090 |
Why?
|
| Algorithms | 2 | 2015 | 1196 | 0.090 |
Why?
|
| Population Surveillance | 3 | 1998 | 285 | 0.090 |
Why?
|
| Societies, Medical | 1 | 2013 | 403 | 0.090 |
Why?
|
| Intraoperative Care | 5 | 1994 | 91 | 0.090 |
Why?
|
| Chronic Disease | 7 | 2002 | 1330 | 0.090 |
Why?
|
| Prospective Studies | 6 | 2005 | 3705 | 0.090 |
Why?
|
| Peripheral Vascular Diseases | 2 | 2003 | 50 | 0.090 |
Why?
|
| Hemostasis, Surgical | 1 | 1989 | 18 | 0.090 |
Why?
|
| HLA-DR Antigens | 2 | 2001 | 41 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2002 | 2324 | 0.080 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 1 | 1988 | 2 | 0.080 |
Why?
|
| Multivariate Analysis | 3 | 2017 | 1046 | 0.080 |
Why?
|
| Forecasting | 2 | 2001 | 277 | 0.080 |
Why?
|
| Cause of Death | 4 | 2000 | 241 | 0.080 |
Why?
|
| Survival Analysis | 8 | 2011 | 714 | 0.080 |
Why?
|
| Adolescent | 13 | 2002 | 8912 | 0.070 |
Why?
|
| Aneurysm, False | 2 | 1998 | 60 | 0.070 |
Why?
|
| Acute Disease | 5 | 2002 | 658 | 0.070 |
Why?
|
| Myocardial Revascularization | 1 | 1987 | 56 | 0.070 |
Why?
|
| Laparoscopy | 2 | 2000 | 237 | 0.070 |
Why?
|
| Arteries | 1 | 1986 | 108 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2005 | 1040 | 0.060 |
Why?
|
| Neck Dissection | 1 | 2005 | 55 | 0.060 |
Why?
|
| Radiotherapy Dosage | 1 | 2005 | 125 | 0.060 |
Why?
|
| Critical Illness | 2 | 2017 | 191 | 0.060 |
Why?
|
| Severity of Illness Index | 3 | 2002 | 1851 | 0.060 |
Why?
|
| Arthroscopy | 1 | 1986 | 95 | 0.060 |
Why?
|
| Plethysmography | 2 | 1984 | 17 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 1998 | 1054 | 0.060 |
Why?
|
| Databases, Factual | 2 | 2018 | 622 | 0.060 |
Why?
|
| Program Development | 2 | 2013 | 240 | 0.060 |
Why?
|
| Colonic Diseases | 1 | 1984 | 36 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 2017 | 384 | 0.060 |
Why?
|
| Aortography | 3 | 2002 | 72 | 0.060 |
Why?
|
| Auscultation | 1 | 1984 | 4 | 0.060 |
Why?
|
| Inflammation | 4 | 2001 | 1030 | 0.060 |
Why?
|
| Diagnostic Imaging | 2 | 2003 | 201 | 0.060 |
Why?
|
| Electroencephalography | 2 | 1991 | 418 | 0.060 |
Why?
|
| Anti-Bacterial Agents | 2 | 2002 | 1026 | 0.060 |
Why?
|
| Intraoperative Complications | 5 | 1994 | 129 | 0.060 |
Why?
|
| Abscess | 2 | 1999 | 37 | 0.060 |
Why?
|
| Methods | 4 | 1993 | 156 | 0.060 |
Why?
|
| Creatinine | 2 | 1995 | 243 | 0.060 |
Why?
|
| Colon | 2 | 1997 | 168 | 0.060 |
Why?
|
| Vascular Patency | 6 | 1998 | 122 | 0.060 |
Why?
|
| Polyethylene Terephthalates | 4 | 1993 | 29 | 0.060 |
Why?
|
| Life Tables | 3 | 2017 | 29 | 0.060 |
Why?
|
| Hemodynamics | 4 | 2002 | 705 | 0.050 |
Why?
|
| Hemorrhage | 3 | 1997 | 328 | 0.050 |
Why?
|
| Venae Cavae | 2 | 1993 | 16 | 0.050 |
Why?
|
| Ergotamines | 1 | 1982 | 3 | 0.050 |
Why?
|
| Warfarin | 1 | 1983 | 93 | 0.050 |
Why?
|
| Embolism | 4 | 2002 | 45 | 0.050 |
Why?
|
| Genes, MHC Class II | 1 | 2002 | 29 | 0.050 |
Why?
|
| Anastomosis, Surgical | 3 | 1998 | 104 | 0.050 |
Why?
|
| Propranolol | 1 | 1982 | 103 | 0.050 |
Why?
|
| Doxycycline | 1 | 2002 | 49 | 0.050 |
Why?
|
| Sensitivity and Specificity | 4 | 2000 | 1753 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2002 | 82 | 0.050 |
Why?
|
| Multiple Organ Failure | 1 | 2002 | 36 | 0.050 |
Why?
|
| Suture Techniques | 1 | 2002 | 75 | 0.050 |
Why?
|
| Aneurysm, Infected | 1 | 2001 | 16 | 0.050 |
Why?
|
| Collagen | 2 | 1999 | 636 | 0.050 |
Why?
|
| APACHE | 1 | 2001 | 41 | 0.050 |
Why?
|
| Surgical Mesh | 1 | 2002 | 57 | 0.050 |
Why?
|
| Monitoring, Physiologic | 3 | 1991 | 219 | 0.050 |
Why?
|
| Health Services Accessibility | 2 | 2013 | 581 | 0.050 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 1993 | 178 | 0.050 |
Why?
|
| Stents | 3 | 2000 | 657 | 0.050 |
Why?
|
| Thrombophlebitis | 2 | 1994 | 47 | 0.050 |
Why?
|
| Transplantation, Autologous | 3 | 2011 | 145 | 0.050 |
Why?
|
| Constriction, Pathologic | 4 | 1992 | 236 | 0.050 |
Why?
|
| Child | 8 | 2002 | 6405 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 2 | 1991 | 296 | 0.050 |
Why?
|
| Diagnosis, Differential | 4 | 2003 | 1140 | 0.050 |
Why?
|
| Brachiocephalic Trunk | 2 | 1991 | 11 | 0.040 |
Why?
|
| Emergency Treatment | 1 | 2000 | 52 | 0.040 |
Why?
|
| Surgical Procedures, Operative | 1 | 2001 | 124 | 0.040 |
Why?
|
| Angioplasty | 1 | 2001 | 118 | 0.040 |
Why?
|
| Aortic Coarctation | 1 | 1980 | 37 | 0.040 |
Why?
|
| Coronary Angiography | 4 | 2002 | 866 | 0.040 |
Why?
|
| Veins | 3 | 1993 | 68 | 0.040 |
Why?
|
| Vascular Neoplasms | 1 | 2000 | 15 | 0.040 |
Why?
|
| Renal Dialysis | 1 | 2001 | 174 | 0.040 |
Why?
|
| Probability | 3 | 1998 | 245 | 0.040 |
Why?
|
| Gelatin | 1 | 1999 | 14 | 0.040 |
Why?
|
| ROC Curve | 1 | 2000 | 392 | 0.040 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2000 | 100 | 0.040 |
Why?
|
| Polyesters | 1 | 1999 | 55 | 0.040 |
Why?
|
| Rifampin | 1 | 1999 | 45 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 4 | 2000 | 219 | 0.040 |
Why?
|
| Biofilms | 1 | 1999 | 72 | 0.040 |
Why?
|
| Materials Testing | 1 | 2000 | 263 | 0.040 |
Why?
|
| Contract Services | 1 | 1998 | 6 | 0.040 |
Why?
|
| Professional Staff Committees | 1 | 1998 | 11 | 0.040 |
Why?
|
| Accidents, Home | 1 | 1998 | 9 | 0.040 |
Why?
|
| Postoperative Care | 3 | 1995 | 163 | 0.040 |
Why?
|
| Recurrence | 2 | 1999 | 948 | 0.040 |
Why?
|
| Aorta, Thoracic | 2 | 1991 | 211 | 0.040 |
Why?
|
| Medicine | 1 | 1998 | 52 | 0.040 |
Why?
|
| Specialization | 1 | 1998 | 66 | 0.040 |
Why?
|
| Viper Venoms | 1 | 1998 | 8 | 0.040 |
Why?
|
| Wounds, Penetrating | 1 | 1998 | 45 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 1998 | 107 | 0.040 |
Why?
|
| Receptors, Endothelin | 1 | 1998 | 30 | 0.040 |
Why?
|
| Foreign Bodies | 1 | 1998 | 58 | 0.040 |
Why?
|
| Angioplasty, Balloon | 3 | 1998 | 110 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 1998 | 186 | 0.040 |
Why?
|
| Ultrasonics | 2 | 1994 | 17 | 0.040 |
Why?
|
| Vasoconstrictor Agents | 1 | 1998 | 107 | 0.040 |
Why?
|
| Respiration, Artificial | 1 | 1998 | 190 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 1988 | 168 | 0.040 |
Why?
|
| Ischemic Attack, Transient | 1 | 1998 | 167 | 0.040 |
Why?
|
| Syndrome | 2 | 2003 | 255 | 0.040 |
Why?
|
| Endothelin-1 | 1 | 1998 | 122 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 1997 | 193 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 1997 | 86 | 0.030 |
Why?
|
| Thromboembolism | 3 | 1985 | 91 | 0.030 |
Why?
|
| Protective Factors | 1 | 2015 | 24 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 536 | 0.030 |
Why?
|
| Dogs | 4 | 2000 | 490 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 1997 | 301 | 0.030 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 69 | 0.030 |
Why?
|
| Peritoneal Dialysis | 1 | 1995 | 30 | 0.030 |
Why?
|
| Phlebography | 1 | 1994 | 31 | 0.030 |
Why?
|
| Streptokinase | 2 | 1985 | 23 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1998 | 931 | 0.030 |
Why?
|
| Angiography, Digital Subtraction | 1 | 1994 | 63 | 0.030 |
Why?
|
| Kidney | 2 | 1996 | 945 | 0.030 |
Why?
|
| Brachial Artery | 2 | 1986 | 34 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 1995 | 150 | 0.030 |
Why?
|
| Fibromuscular Dysplasia | 1 | 1993 | 2 | 0.030 |
Why?
|
| Thoracic Nerves | 1 | 1993 | 2 | 0.030 |
Why?
|
| Stellate Ganglion | 1 | 1993 | 9 | 0.030 |
Why?
|
| Hepatic Artery | 1 | 1993 | 25 | 0.030 |
Why?
|
| Sympathectomy | 1 | 1993 | 24 | 0.030 |
Why?
|
| Urokinase-Type Plasminogen Activator | 2 | 1983 | 26 | 0.030 |
Why?
|
| Raynaud Disease | 1 | 1993 | 24 | 0.030 |
Why?
|
| Health Planning Guidelines | 1 | 2013 | 23 | 0.030 |
Why?
|
| Subclavian Vein | 1 | 1992 | 17 | 0.030 |
Why?
|
| Spinal Cord | 2 | 1991 | 244 | 0.030 |
Why?
|
| Health Care Rationing | 1 | 2013 | 32 | 0.030 |
Why?
|
| Pregnancy Complications | 1 | 1995 | 286 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2011 | 737 | 0.030 |
Why?
|
| Hypertension | 1 | 2002 | 1535 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2000 | 2550 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2015 | 294 | 0.030 |
Why?
|
| Leiomyosarcoma | 1 | 1992 | 17 | 0.030 |
Why?
|
| Coronary Artery Bypass | 1 | 1993 | 218 | 0.030 |
Why?
|
| Fluoresceins | 1 | 1992 | 31 | 0.030 |
Why?
|
| Morbidity | 3 | 2002 | 130 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2013 | 149 | 0.020 |
Why?
|
| Ankle Brachial Index | 1 | 2011 | 10 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2011 | 44 | 0.020 |
Why?
|
| Arm | 2 | 1989 | 59 | 0.020 |
Why?
|
| Colonoscopy | 1 | 1993 | 156 | 0.020 |
Why?
|
| Lumbosacral Plexus | 1 | 1991 | 15 | 0.020 |
Why?
|
| Endothelins | 1 | 1991 | 57 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2013 | 235 | 0.020 |
Why?
|
| Body Water | 1 | 1991 | 35 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2013 | 252 | 0.020 |
Why?
|
| Demography | 1 | 2011 | 279 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 217 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 1990 | 54 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 2077 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 1991 | 219 | 0.020 |
Why?
|
| Pregnancy | 1 | 1995 | 2334 | 0.020 |
Why?
|
| Transfusion Reaction | 1 | 1989 | 33 | 0.020 |
Why?
|
| Technetium Compounds | 1 | 1989 | 1 | 0.020 |
Why?
|
| Lymphedema | 1 | 1989 | 6 | 0.020 |
Why?
|
| Lymphoscintigraphy | 1 | 1989 | 5 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2018 | 1034 | 0.020 |
Why?
|
| Cardiac Output | 2 | 2000 | 133 | 0.020 |
Why?
|
| Cranial Nerves | 1 | 1988 | 3 | 0.020 |
Why?
|
| Posture | 1 | 1988 | 107 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 1996 | 839 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1988 | 37 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 706 | 0.020 |
Why?
|
| Physical Exertion | 2 | 1986 | 75 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2011 | 1738 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 1986 | 940 | 0.020 |
Why?
|
| Carcinoma | 1 | 1989 | 215 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 1342 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2002 | 652 | 0.020 |
Why?
|
| Diabetic Angiopathies | 1 | 1988 | 203 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1988 | 141 | 0.020 |
Why?
|
| Prosthesis Design | 1 | 1988 | 301 | 0.020 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 1986 | 20 | 0.020 |
Why?
|
| Carotid Artery Injuries | 1 | 1986 | 26 | 0.020 |
Why?
|
| Pentoxifylline | 1 | 1986 | 12 | 0.020 |
Why?
|
| Subtraction Technique | 1 | 1986 | 12 | 0.020 |
Why?
|
| Synovial Cyst | 1 | 1986 | 4 | 0.020 |
Why?
|
| Laser Therapy | 1 | 1986 | 54 | 0.020 |
Why?
|
| Blood Sedimentation | 1 | 1985 | 16 | 0.020 |
Why?
|
| Femoral Vein | 1 | 1985 | 15 | 0.020 |
Why?
|
| Ulcer | 1 | 1985 | 27 | 0.020 |
Why?
|
| Foot Diseases | 1 | 1985 | 20 | 0.020 |
Why?
|
| Toes | 1 | 1985 | 27 | 0.020 |
Why?
|
| Rest | 1 | 1985 | 78 | 0.020 |
Why?
|
| Tibia | 1 | 1986 | 93 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1985 | 215 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 1994 | 1085 | 0.020 |
Why?
|
| Emergencies | 2 | 1996 | 107 | 0.020 |
Why?
|
| Phonocardiography | 1 | 1984 | 2 | 0.010 |
Why?
|
| Paraplegia | 2 | 1996 | 28 | 0.010 |
Why?
|
| Drainage | 1 | 1984 | 133 | 0.010 |
Why?
|
| Budd-Chiari Syndrome | 1 | 1983 | 7 | 0.010 |
Why?
|
| Colorectal Neoplasms | 1 | 1989 | 561 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 1986 | 419 | 0.010 |
Why?
|
| Eye | 1 | 1984 | 89 | 0.010 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1983 | 27 | 0.010 |
Why?
|
| Ergotamine | 1 | 1982 | 1 | 0.010 |
Why?
|
| United Kingdom | 1 | 2003 | 152 | 0.010 |
Why?
|
| Length of Stay | 1 | 1986 | 780 | 0.010 |
Why?
|
| Foot | 1 | 1983 | 66 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 1982 | 81 | 0.010 |
Why?
|
| Mesenteric Arteries | 1 | 2002 | 29 | 0.010 |
Why?
|
| Biomarkers | 2 | 2002 | 1593 | 0.010 |
Why?
|
| Blood Pressure Determination | 1 | 1983 | 152 | 0.010 |
Why?
|
| Reference Standards | 1 | 2002 | 115 | 0.010 |
Why?
|
| Pain | 1 | 1985 | 472 | 0.010 |
Why?
|
| Maryland | 1 | 2002 | 77 | 0.010 |
Why?
|
| Migraine Disorders | 1 | 1982 | 66 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2002 | 219 | 0.010 |
Why?
|
| Collateral Circulation | 2 | 1991 | 34 | 0.010 |
Why?
|
| Neoplasms | 1 | 1993 | 1667 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2002 | 160 | 0.010 |
Why?
|
| Graft Survival | 2 | 1996 | 465 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2002 | 138 | 0.010 |
Why?
|
| Ophthalmic Artery | 1 | 1980 | 4 | 0.010 |
Why?
|
| Brain Ischemia | 2 | 1991 | 665 | 0.010 |
Why?
|
| Carotid Artery Thrombosis | 1 | 1980 | 7 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1982 | 649 | 0.010 |
Why?
|
| Surgical Wound Infection | 1 | 2002 | 168 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2003 | 438 | 0.010 |
Why?
|
| Urea | 1 | 2000 | 51 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1980 | 100 | 0.010 |
Why?
|
| Epinephrine | 1 | 2000 | 103 | 0.010 |
Why?
|
| Decision Making | 1 | 2003 | 410 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2002 | 402 | 0.010 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2000 | 85 | 0.010 |
Why?
|
| Animals | 4 | 2000 | 20881 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 848 | 0.010 |
Why?
|
| Random Allocation | 1 | 2000 | 442 | 0.010 |
Why?
|
| Disease Progression | 1 | 2002 | 1038 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 2000 | 291 | 0.010 |
Why?
|
| Sex Factors | 1 | 2002 | 1266 | 0.010 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 1998 | 17 | 0.010 |
Why?
|
| Receptor, Endothelin B | 1 | 1998 | 34 | 0.010 |
Why?
|
| Receptor, Endothelin A | 1 | 1998 | 35 | 0.010 |
Why?
|
| Pulmonary Circulation | 1 | 1998 | 79 | 0.010 |
Why?
|
| Intervertebral Disc | 1 | 1998 | 51 | 0.010 |
Why?
|
| Dopamine | 1 | 2000 | 474 | 0.010 |
Why?
|
| Prevalence | 1 | 2002 | 1619 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 1998 | 112 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 1992 | 446 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2000 | 2223 | 0.010 |
Why?
|
| HLA-DQ beta-Chains | 1 | 1997 | 5 | 0.010 |
Why?
|
| HLA-DRB1 Chains | 1 | 1997 | 21 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 1998 | 136 | 0.010 |
Why?
|
| Vascular Resistance | 1 | 1998 | 179 | 0.010 |
Why?
|
| HLA-DQ Antigens | 1 | 1997 | 19 | 0.010 |
Why?
|
| Giant Cell Arteritis | 1 | 1997 | 10 | 0.010 |
Why?
|
| Insulin | 1 | 2000 | 619 | 0.010 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 1996 | 3 | 0.010 |
Why?
|
| Homeostasis | 1 | 1998 | 291 | 0.010 |
Why?
|
| Sutures | 1 | 1996 | 32 | 0.010 |
Why?
|
| Alleles | 1 | 1997 | 386 | 0.010 |
Why?
|
| Carbon Dioxide | 1 | 1996 | 78 | 0.010 |
Why?
|
| Polypropylenes | 1 | 1996 | 31 | 0.010 |
Why?
|
| Perfusion | 1 | 1996 | 131 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1997 | 492 | 0.010 |
Why?
|
| Heart Rate | 1 | 1998 | 568 | 0.010 |
Why?
|
| Blood Loss, Surgical | 1 | 1996 | 79 | 0.010 |
Why?
|
| Debridement | 1 | 1995 | 55 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 1996 | 93 | 0.010 |
Why?
|
| Thrombectomy | 1 | 1998 | 238 | 0.010 |
Why?
|
| Mesenteric Veins | 1 | 1994 | 10 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1997 | 1083 | 0.010 |
Why?
|
| Swine | 1 | 1996 | 672 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1996 | 250 | 0.010 |
Why?
|
| Diabetic Foot | 1 | 1994 | 33 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 1995 | 156 | 0.010 |
Why?
|
| Horner Syndrome | 1 | 1993 | 8 | 0.010 |
Why?
|
| Mesenteric Artery, Superior | 1 | 1993 | 8 | 0.010 |
Why?
|
| Infarction | 1 | 1993 | 17 | 0.010 |
Why?
|
| Hypertension, Renal | 1 | 1993 | 29 | 0.010 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1993 | 28 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1994 | 951 | 0.010 |
Why?
|
| Fluorescein | 1 | 1992 | 15 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 1993 | 121 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1994 | 356 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1993 | 369 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 1991 | 24 | 0.010 |
Why?
|
| Constriction | 1 | 1991 | 37 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1992 | 130 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 1991 | 69 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1998 | 3187 | 0.010 |
Why?
|
| Water-Electrolyte Balance | 1 | 1991 | 43 | 0.010 |
Why?
|
| Permeability | 1 | 1991 | 131 | 0.010 |
Why?
|
| Subclavian Artery | 1 | 1991 | 30 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 1991 | 149 | 0.010 |
Why?
|
| Free Radical Scavengers | 1 | 1991 | 112 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1991 | 317 | 0.010 |
Why?
|
| Takayasu Arteritis | 1 | 1989 | 2 | 0.010 |
Why?
|
| Lymphatic System | 1 | 1989 | 5 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1991 | 371 | 0.010 |
Why?
|
| Antimony | 1 | 1989 | 6 | 0.010 |
Why?
|
| Colloids | 1 | 1989 | 43 | 0.010 |
Why?
|
| Technetium | 1 | 1989 | 38 | 0.010 |
Why?
|
| Graft Rejection | 1 | 1992 | 458 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1991 | 1174 | 0.010 |
Why?
|
| Colectomy | 1 | 1989 | 64 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1989 | 238 | 0.000 |
Why?
|
| Paralysis | 1 | 1988 | 35 | 0.000 |
Why?
|
| Reperfusion Injury | 1 | 1991 | 320 | 0.000 |
Why?
|
| Rhinitis | 1 | 1993 | 383 | 0.000 |
Why?
|
| Respiratory Insufficiency | 1 | 1988 | 76 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1988 | 306 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1989 | 800 | 0.000 |
Why?
|
| Kidney Diseases | 1 | 1988 | 307 | 0.000 |
Why?
|
| Thromboangiitis Obliterans | 1 | 1985 | 2 | 0.000 |
Why?
|
| Arteritis | 1 | 1985 | 4 | 0.000 |
Why?
|
| Body Weight | 1 | 1979 | 554 | 0.000 |
Why?
|